Epigenetic biomarkers in urological tumors: A systematic review

被引:72
作者
Jeronimo, Carmen [1 ,2 ,4 ]
Henrique, Rui [1 ,3 ,4 ]
机构
[1] Portuguese Oncol Inst, Res Ctr, Canc Epigenet Grp, P-4200072 Oporto, Portugal
[2] Portuguese Oncol Inst, Dept Genet, P-4200072 Oporto, Portugal
[3] Portuguese Oncol Inst, Dept Pathol, P-4200072 Oporto, Portugal
[4] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, P-4099003 Oporto, Portugal
关键词
Epigenetic-based biomarkers; Genitourinary cancer; DNA methylation; Histone modifications; microRNAs; CPG ISLAND HYPERMETHYLATION; PROSTATE-CANCER DETECTION; GLOBAL DNA-METHYLATION; RENAL-CELL CARCINOMA; ABERRANT PROMOTER METHYLATION; HISTONE MODIFICATION PATTERNS; POLYMERASE-CHAIN-REACTION; ANTAGONIST FAMILY GENES; GROUP PROTEIN EZH2; BLADDER-CANCER;
D O I
10.1016/j.canlet.2011.12.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate, bladder, kidney and testis cancers, the most common genitourinary (GU) neoplasms, are generally clinically silent at their earliest stages when curative treatment is most likely successful. However, there are no consensual guidelines for GU cancer screening and available methods are characterized by suboptimal sensitivity and specificity. Moreover, standard clinical and pathological parameters meet with important limitations in the assessment of prognosis in an individual basis. Herein, we focus on the development of epigenetic-based GU cancer biomarkers, which have emerged from exploratory studies in recent years and that hold the promise to revolutionize the clinical management of GU cancer patients. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 274
页数:11
相关论文
共 157 条
[31]   Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples [J].
Costa, Vera L. ;
Henrique, Rui ;
Danielsen, Stine A. ;
Duarte-Pereira, Sara ;
Eknaes, Mette ;
Skotheim, Rolf I. ;
Rodrigues, Angelo ;
Magalhaes, Jose S. ;
Oliveira, Jorge ;
Lothe, Ragnhild A. ;
Teixeira, Manuel R. ;
Jeronimo, Carmen ;
Lind, Guro E. .
CLINICAL CANCER RESEARCH, 2010, 16 (23) :5842-5851
[32]   Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis [J].
Cottrell, Susan ;
Jung, Klaus ;
Kristiansen, Glen ;
Eltze, Elke ;
Semjonow, Axel ;
Ittmann, Michael ;
Hartmann, Arndt ;
Stamey, Thomas ;
Haefliger, Carolina ;
Weiss, Gunter .
JOURNAL OF UROLOGY, 2007, 177 (05) :1753-1758
[33]   Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers [J].
Devaney, James ;
Stirzaker, Clare ;
Qu, Wenjia ;
Song, Jenny Z. ;
Statham, Aaron L. ;
Patterson, Kate I. ;
Horvath, Lisa G. ;
Tabor, Bruce ;
Coolen, Marcel W. ;
Hulf, Toby ;
Kench, James G. ;
Henshall, Susan M. ;
Benito, Ruth Pe ;
Haynes, Anne-Maree ;
Mayor, Regina ;
Peinado, Miguel A. ;
Sutherland, Robert L. ;
Clark, Susan J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (01) :148-159
[34]  
DeVita V., 2008, Cancer: Principles and Practice of Oncology, V8th
[35]   Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts [J].
Doi, Akiko ;
Park, In-Hyun ;
Wen, Bo ;
Murakami, Peter ;
Aryee, Martin J. ;
Irizarry, Rafael ;
Herb, Brian ;
Ladd-Acosta, Christine ;
Rho, Junsung ;
Loewer, Sabine ;
Miller, Justine ;
Schlaeger, Thorsten ;
Daley, George Q. ;
Feinberg, Andrew P. .
NATURE GENETICS, 2009, 41 (12) :1350-U123
[36]  
Domínguez G, 2002, CLIN CANCER RES, V8, P980
[37]   Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma [J].
Duarte-Pereira, Sara ;
Paiva, Filipa ;
Costa, Vera Lucia ;
Ramalho-Carvalho, Joao ;
Savva-Borclalo, Joana ;
Rodrigues, Angelo ;
Ribeiro, Franclim Ricardo ;
Silva, Vitor M. ;
Oliveira, Jorge ;
Henrique, Rui ;
Jeronimo, Carmen .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) :1106-1114
[38]   Hypermethylation of CpG Islands and Shores around Specific MicroRNAs and Mirtrons Is Associated with the Phenotype and Presence of Bladder Cancer [J].
Dudziec, Ewa ;
Miah, Saiful ;
Choudhry, Hani M. Z. ;
Owen, Helen C. ;
Blizard, Sheila ;
Glover, Maggie ;
Hamdy, Freddie C. ;
Catto, James W. F. .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1287-1296
[39]   Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel [J].
Dulaimi, E ;
Uzzo, RG ;
Greenberg, RE ;
Al-Saleem, T ;
Cairns, P .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :1887-1893
[40]   Promoter hypermethylation profile of kidney cancer [J].
Dulaimi, E ;
Ibanez de Caceres, I ;
Uzzo, RG ;
Al-Saleem, T ;
Greenberg, RE ;
Polascik, TJ ;
Babb, JS ;
Grizzle, WE ;
Cairns, P .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :3972-3979